The global dental resin market is poised for significant growth, with recent analyses estimating a rise from USD 1.4 billion ...

For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...

PRESS RELEASEOMass Therapeutics appoints Birgitte Volck as Non-Executive DirectorOxford, United Kingdom – 26 February 2025 – ...

In the 2024 financial year, Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin at 36.1%. The sales growth is driven by both Food & Health Biosolutions and Planetary Health ...

Galen Limited, a leading pharmaceutical sales and marketing company, has announced a significant step in its global expansion by signing an exclusive licensing agreement with Taiwan-based Bora Health ...

Canon Medical Systems is proud to introduce the Vantage Galan 3T / Supreme Edition, its latest innovative MRI system at the European Congress of Radiology (ECR) 2025. This innovation reflects Canon ...

Today, at the 7th Patient Centricity & Collaboration World Congress in London, The Bloc unveiled In.Pazienti, a global community that connects, supports, and amplifies the voices of patients through ...

ViCentra B.V., the company behind Kaleido, one of the world's smallest, lightest, and most precise insulin patch pump and automated insulin delivery (AID) system, today announced the appointment of ...

Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2024. Riad Mishlawi, Chief Executive Officer ...

LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook for the year, putting the company on track to meet its ...

Genmab A/S (Nasdaq: GMAB) will increase its share capital by 10,058 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the ...

Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program.1 Lilly also ...